PHATHOM PHARMACEUTICALS, INC. Employee Count
The employee counts PHATHOM PHARMACEUTICALS, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 371; Filing 2026-02-26; Lease expense per employee $18,598.38.
- 2024-12-31: Employees (as filed) 427; Filing 2025-03-06; Lease expense per employee $20,608.90.
- 2023-12-31: Employees (as filed) 452; Filing 2024-03-07.
- 2022-12-31: Employees (as filed) 112; Filing 2023-02-28.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 371 full-time | 2026-02-26 | $18,598.38 short-term |
| 2024-12-31 | 427 full-time | 2025-03-06 | $20,608.90 short-term |
| 2023-12-31 | 452 full-time | 2024-03-07 | |
| 2022-12-31 | 112 full-time | 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |